Image-guided brachytherapy (IGBT) combined with whole pelvic intensity-modulated radiotherapy (WP-IMRT) for locally advanced cervical cancer: A prospective study from Chiang Mai University Hospital, Thailand

Journal of Contemporary Brachytherapy

Volumn 5, Issue 1, 2013, Pages 10-16

  Tharavichitkul, Ekkasit ^a   Wanwilairat, Somsak ^a   Chakrabandhu, Somvilai ^a   Klunklin, Pitchayaponne ^a   Onchan, Wimrak ^a   Tippanya, Damrongsak ^a   Nopnop, Wannapa ^a   Galalae, Razvan ^b   Chitapanarux, Imjai ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Brachytherapy; Cervical cancer; IGBT; IMRT

Indexed keywords

CISPLATIN; IRIDIUM 192;

ADULT; ADVANCED CANCER; ARTICLE; BLADDER; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CREATININE CLEARANCE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HISTOGRAM; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; METASTASIS FREE SURVIVAL; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RECTUM; SIGMOID; THAILAND; UNIVERSITY HOSPITAL; UTERINE CERVIX CANCER;

EID: 84876837570     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2013.34338     Document Type: Article

References (28)

1. Kamnerdsupaphon P, Srisukho S, Sumitsawan Y et al. Cancers in Northern Thailand. Biomed Imaging Interv J 2008; 4: e46.
2. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-1153. (Pubitemid 29177873)
3. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154-1161. (Pubitemid 29177874)
4. Eifel PJ, Winter K, Morris M et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 2004; 22: 872-880. (Pubitemid 41103599)
5. Loiselle C, Koh WJ. The emerging use of IMRT for treatment of cervical cancer. J Natl Compr Canc Netw 2010; 8: 1425-1434.
6. Mundt AJ, Lujan AE, Rotmensch J et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002; 52: 1330-1337. (Pubitemid 34296492)
7. Hasselle MD, Rose BS, Kochanski JD et al. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2011; 80: 1436-1445.
8. Haie-Meder C, Pötter R, Van Limbergen E et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-245. (Pubitemid 40349132)
9. Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO Working Group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77. (Pubitemid 43131038)
10. Pötter R, Dimopoulos J, Georg P et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007; 83: 148-155. (Pubitemid 46783926)
11. Pötter R, Georg P, Dimopoulos JC et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011; 100: 116-123.
12. Tan LT, Coles CE, Hart C et al. Clinical impact of computed tomography-based imaged-guided brachytherapy for cervix cancer using the tandem-ring applicator-the Addenbrooke's experience. Clin Oncol (R Coll Radiol) 2009; 21: 175-182.
13. Lim K, Small W Jr, Portelance L et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys 2011; 79: 348-355.
14. Taylor A, Rockall AG, Reznek RH et al. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005; 63: 1604-1612. (Pubitemid 41628062)
15. Toita T, Ohno T, Kaneyasu Y et al. A Consensus-based Guideline Defining the Clinical Target Volume for Pelvic Lymph Nodes in External Beam Radiotherapy for Uterine Cervical Cancer. Jpn J Clin Oncol 2010; 40: 456-463.
16. Toita T, Ohno T, Kaneyasu Y et al. A Consensus-based Guideline Defining Clinical Target Volume for Primary Disease in External Beam Radiotherapy for Intact Uterine Cervical Cancer. Jpn J Clin Oncol 2011; 41: 1119-1126.
17. Bentzen SM, Joiner MC. The linear-quadratic approach in clinical practice. In: Basic clinical radiobiology. Joiner M, Van Der Kogel A (eds.). 4th ed. Edward Arnold, London 2009, pp. 120-134.
18. Viswanathan AN, Dimopoulos JC, Kirisits C et al. Computed tomography versus magnetic resonance image-based contouring in cervical cancer brachytherapy: result of a prospective trial and preliminary guidelines for standard contours. Int J Radiat Oncol Biol Phys 2007; 68: 491-498. (Pubitemid 46694166)
19. Portelance L, Chao KS, Grigsby PW et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001; 51: 261-266. (Pubitemid 32758886)
20. Chen CC, Lin JC, Jan JS et al. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer. Gynecol Oncol 2011; 122: 9-13.
21. De Brabandere M, Mousa AG, Nulens A et al. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2008; 88: 217-226.
22. Tanderup K, Nielsen SK, Nyvang GB et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol 2010; 94: 173-180.
23. Zwahlen D, Jezioranski J, Chan P et al. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. Int J Radiat Oncol Biol Phys 2009; 74: 1157-1164.
24. Haie-Meder C, Chargari C, Rey A et al. MRI-based low doserate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol 2010; 96: 161-165.
25. Charra-Brunaud C, Harter V, Delannes M et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol 2012; 103: 305-313.
26. Beriwal S, Kannan N, Kim H et al. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results. Clin Oncol (R Coll Radiol) 2011; 23: 685-690.
27. Tharavichitkul E, Sivasomboon C, Wanwilairat S, et al. Preliminary results of MRI-guided brachytherapy in cervical carcinoma: the Chiangmai University experience. J Radiat Res 2012; 53: 313-318.
28. Tharavichitkul E, Mayurasakorn S, Lorvidhaya V et al. Preliminary Results of Conformal Computed Tomography (CT)-based Intracavitary Brachytherapy (ICBT) for Locally Advanced Cervical Cancer: A Single Institution's Experience. J Radiat Res 2011; 52: 634-640.